Zhejiang Starry Pharm Co Ltd
Zhejiang Starry Pharmaceutical Co.,Ltd., together with its subsidiaries, engages in the research, development, production, and sale of pharmaceutical raw materials in China and internationally. It operates through Contrast Agent Series, Quinolone Series, CMO/CDMO, and Others segments. The company offers preparation products comprising iohexol, iopamidol, iodixanol, iomeprol, ioversol, and gadoben… Read more
Zhejiang Starry Pharm Co Ltd (603520) - Cash Flow Conversion Efficiency
Latest cash flow conversion efficiency as of September 2025: 0.004x
Based on the latest financial reports, Zhejiang Starry Pharm Co Ltd (603520) has a cash flow conversion efficiency ratio of 0.004x as of September 2025.
Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (CN¥9.76 Million) by net assets (CN¥2.61 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.
Zhejiang Starry Pharm Co Ltd - Cash Flow Conversion Efficiency Trend (2011–2024)
This chart illustrates how Zhejiang Starry Pharm Co Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. Explore and compare other companies by cash flow conversion efficiency.
Zhejiang Starry Pharm Co Ltd Competitors by Cash Flow Conversion Efficiency
The table below lists competitors of Zhejiang Starry Pharm Co Ltd ranked by their cash flow conversion efficiency.
| Company | Cash Flow Conversion Efficiency |
|---|---|
|
GREAT STHN BANCORP DL-01
F:GS6
|
N/A |
|
Hanon Systems
KO:018880
|
0.023x |
|
Anhui Xinli Finance Co Ltd
SHG:600318
|
0.060x |
|
Zhejiang Xinao Textiles Inc
SHG:603889
|
0.064x |
|
Jupiter Fund Management Plc
PINK:JFHHF
|
0.024x |
|
MANDARIN ORIENTAL DL-05
F:1C4
|
0.007x |
|
HERTZ GL. HOLD. INC. NEW
F:AZK0
|
N/A |
|
General Interface Solution GIS Holding Ltd
TW:6456
|
0.052x |
Annual Cash Flow Conversion Efficiency for Zhejiang Starry Pharm Co Ltd (2011–2024)
The table below shows the annual cash flow conversion efficiency of Zhejiang Starry Pharm Co Ltd from 2011 to 2024.
| Year | Net Assets | Operating Cash Flow | Cash Flow Conversion Efficiency | Change |
|---|---|---|---|---|
| 2024-12-31 | CN¥2.63 Billion | CN¥193.50 Million | 0.073x | +180.09% |
| 2023-12-31 | CN¥1.76 Billion | CN¥46.13 Million | 0.026x | +159.27% |
| 2022-12-31 | CN¥1.77 Billion | CN¥-78.37 Million | -0.044x | -119.26% |
| 2021-12-31 | CN¥2.21 Billion | CN¥508.84 Million | 0.230x | +145.57% |
| 2020-12-31 | CN¥1.86 Billion | CN¥174.48 Million | 0.094x | -60.99% |
| 2019-12-31 | CN¥1.03 Billion | CN¥246.77 Million | 0.240x | +15.41% |
| 2018-12-31 | CN¥922.96 Million | CN¥191.84 Million | 0.208x | +901.60% |
| 2017-12-31 | CN¥872.44 Million | CN¥18.10 Million | 0.021x | +123.47% |
| 2016-12-31 | CN¥827.01 Million | CN¥7.68 Million | 0.009x | -95.52% |
| 2015-12-31 | CN¥457.70 Million | CN¥94.88 Million | 0.207x | -37.79% |
| 2014-12-31 | CN¥432.13 Million | CN¥144.00 Million | 0.333x | +71.57% |
| 2013-12-31 | CN¥386.11 Million | CN¥74.99 Million | 0.194x | -36.70% |
| 2012-12-31 | CN¥336.81 Million | CN¥103.34 Million | 0.307x | +325.46% |
| 2011-12-31 | CN¥301.81 Million | CN¥-41.07 Million | -0.136x | -- |